Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- DA Davidson analyst Peter Winter initiated coverage on First Horizon Corporation (NYSE: FHN) with a Neutral rating and announced a price target of $24. First Horizon shares closed at $22.66 on Thursday. See how other analysts view this stock.
- JP Morgan analyst Tomohiko Sano initiated coverage on Valmont Industries, Inc. (NYSE: VMI) with an Overweight rating and announced a price target of $480. Valmont shares closed at $364.66 on Thursday. See how other analysts view this stock.
- LUCID CAPITAL MARKETS analyst Christopher Liu initiated coverage on Lyell Immunopharma, Inc. (NASDAQ: LYEL) with a Buy rating and announced a price target of $20. Lyell Immunopharma shares closed at $12.72 on Thursday. See how other analysts view this stock.
- Deutsche Bank analyst David Hoang initiated coverage on Spyre Therapeutics, Inc. (NASDAQ: SYRE) with a Buy rating and announced a price target of $43. Spyre Therapeutics shares closed at $15.61 on Thursday. See how other analysts view this stock.
- RBC Capital analyst Lisa Walter initiated coverage on United Therapeutics Corporation (NASDAQ: UTHR) with an Outperform rating and announced a price target of $569. United Therapeutics shares closed at $425.42 on Thursday. See how other analysts view this stock.
Considering buying UTHR stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
